Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 67

Results For "UK"

989 News Found

AIIA signs MoU with AIST
Policy | October 09, 2022

AIIA signs MoU with AIST

The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines


Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment
News | October 04, 2022

Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment

Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.


2.5 lakh+ people voluntarily donated blood under the Raktdaan Amrit Mahotsav
News | October 03, 2022

2.5 lakh+ people voluntarily donated blood under the Raktdaan Amrit Mahotsav

Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work


Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister
Policy | October 01, 2022

Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister

Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India


NIHR addresses research in surgery in India
News | September 28, 2022

NIHR addresses research in surgery in India

The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit


Mylab receives approval for HPV RT-PCR test for cervical cancers
Clinical Trials | September 28, 2022

Mylab receives approval for HPV RT-PCR test for cervical cancers

‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.


There should be no space for fraud in AB-PMJAY: Dr. Mandaviya
Policy | September 27, 2022

There should be no space for fraud in AB-PMJAY: Dr. Mandaviya

The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations


India achieves significant landmark in reduction of child mortality rates
Policy | September 24, 2022

India achieves significant landmark in reduction of child mortality rates

The country has been witnessing a progressive reduction in IMR, U5MR and NMR


19 crore AB-PMJAY cards created; 3.8 crore beneficiaries avails free benefit
Policy | September 24, 2022

19 crore AB-PMJAY cards created; 3.8 crore beneficiaries avails free benefit

AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds


BridgeBio Pharma, Sentynl Therapeutics receive marketing authorization in the EU for fosdenopterin
Drug Approval | September 22, 2022

BridgeBio Pharma, Sentynl Therapeutics receive marketing authorization in the EU for fosdenopterin

NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.